2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Chromosome 8, trisomy: new trials by email Literature Review of Chromosome 8, trisomy trials Research Report on Chromosome 8, trisomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Int-1 or Trisomy 8 Int-2 Myelodysplastic Syndrome rigosertib - Myelodysplastic Syndrome, MDS | Phase 2 | Completed | Traws Pharma, Inc. | 82 | 2012-05-01 | 2017-06-26 |
| Efficacy and Safety of ON 01910.Na in Myelodysplastic Syndrome (MDS) Patients With Trisomy 8 or Classified as Intermediate-1, -2 or High Risk ON 01910.Na - Myelodysplastic Syndrome | Phase 2 | Completed | Traws Pharma, Inc. | 14 | 2009-05-01 | 2017-06-26 |
Bone Marrow Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2)
ON 01910 (2)
United States (2)
Peter L. Greenberg, MD (1) · Steven M. Fruchtman, MD (1)